The DOI matches its Crossref record; 140 of the 140 references it cites were found in a registry or an index.
Targeting bacterial membrane function: an underexploited mechanism for treating persistent infections
Open accessAbstract
Persistent infections involving slow-growing or non-growing bacteria are hard to treat with antibiotics that target biosynthetic processes in growing cells. Consequently, there is a need for antimicrobials that can treat infections containing dormant bacteria. In this Review, we discuss the emerging concept that disrupting the bacterial membrane bilayer or proteins that are integral to membrane function (including membrane potential and energy metabolism) in dormant bacteria is a strategy for treating persistent infections. The clinical applicability of these approaches is exemplified by the efficacy of lipoglycopeptides that damage bacterial membranes and of the diarylquinoline TMC207, which inhibits membrane-bound ATP synthase. Despite some drawbacks, membrane-active agents form an important new means of eradicating recalcitrant, non-growing bacteria.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bacterial Biofilms: A Common Cause of Persistent Infections
Costerton, J. W., Stewart, P. S., & Greenberg, E. P. (1999) · Science · doi:10.1126/science.284.5418.1318 · Cited by 12,167
Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?
Brogden, K. A. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1098 · Cited by 5,829
Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies
Hancock, R. E. W., & Sahl, H.-G. (2006) · Nature Biotechnology · doi:10.1038/nbt1267 · Cited by 4,208
A Common Mechanism of Cellular Death Induced by Bactericidal Antibiotics
Kohanski, M. A., Dwyer, D. J., Hayete, B., Lawrence, C. A., & Collins, J. J. (2007) · Cell · doi:10.1016/j.cell.2007.06.049 · Cited by 2,982
Drugs for bad bugs: confronting the challenges of antibacterial discovery
Payne, D. J., Gwynn, M. N., Holmes, D. J., & Pompliano, D. L. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2201 · Cited by 2,512
Physiological heterogeneity in biofilms
Stewart, P. S., & Franklin, M. J. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro1838 · Cited by 2,327
A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosis
Andries, K., Verhasselt, P., Guillemont, J., Göhlmann, H. W. H., Neefs, J.-M., Winkler, H., Van Gestel, J., Timmerman, P., Zhu, M., Lee, E., et al. (2005) · Science · doi:10.1126/science.1106753 · Cited by 2,191 · cited 1×
“TMC207 specifically binds to subunit C of the mycobacterial F 0 F 1 -ATPase, sterically blocking the enzyme's rotational motor and thereby inhibiting proton translocation and coupled ATP biosynthesi”
Persister cells, dormancy and infectious disease
Lewis, K. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1557 · Cited by 2,052
Lewis, K. (2010) · Annual Review of Microbiology · doi:10.1146/annurev.micro.112408.134306 · Cited by 1,858
Baddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Bolger, A. F., Levison, M. E., Ferrieri, P., Gerber, M. A., Tani, L. Y., Gewitz, M. H., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.165564 · Cited by 1,707
The spectrum of latent tuberculosis: rethinking the biology and intervention strategies
Barry, C. E., Boshoff, H. I., Dartois, V., Dick, T., Ehrt, S., Flynn, J., Schnappinger, D., Wilkinson, R. J., & Young, D. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2236 · Cited by 1,422
Membrane lipid homeostasis in bacteria
Zhang, Y.-M., & Rock, C. O. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro1839 · Cited by 1,393 · cited 1×
“; similarly, the composition of membrane lipids may vary between different subpopulations of persistent cell”
TREATMENT OF STAPHYLOCOCCAL INFECTIONS WITH PENICILLIN BY INTERMITTENT STERILISATION
Bigger, J. (1944) · The Lancet · doi:10.1016/s0140-6736(00)74210-3 · Cited by 1,178
Verkleij, A. J., Zwaal, R. F. A., Roelofsen, B., Comfurius, P., Kastelijn, D., & van Deenen, L. L. M. (1973) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(73)90143-0 · Cited by 1,106
Vancomycin Resistance in Gram-Positive Cocci
Courvalin, P. (2006) · Clinical Infectious Diseases · doi:10.1086/491711 · Cited by 1,028
The Diarylquinoline TMC207 for Multidrug-Resistant Tuberculosis
Diacon, A. H., Pym, A., Grobusch, M., Patientia, R., Rustomjee, R., Page-Shipp, L., Pistorius, C., Krause, R., Bogoshi, M., Churchyard, G., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808427 · Cited by 835
Dowd, S. E., Sun, Y., Secor, P. R., Rhoads, D. D., Wolcott, B. M., James, G. A., & Wolcott, R. D. (2008) · BMC Microbiology · doi:10.1186/1471-2180-8-43 · Cited by 784
The future challenges facing the development of new antimicrobial drugs
Coates, A., Hu, Y., Bax, R., & Page, C. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd940 · Cited by 704
Human Host Defense Peptide LL-37 Prevents Bacterial Biofilm Formation
Overhage, J., Campisano, A., Bains, M., Torfs, E. C. W., Rehm, B. H. A., & Hancock, R. E. W. (2008) · Infection and Immunity · doi:10.1128/iai.00318-08 · Cited by 696
The chlamydial developmental cycle: Figure 1
AbdelRahman, Y. M., & Belland, R. J. (2005) · FEMS Microbiology Reviews · doi:10.1016/j.femsre.2005.03.002 · Cited by 631
The Transcriptional Responses of Mycobacterium tuberculosis to Inhibitors of Metabolism
Boshoff, H. I. M., Myers, T. G., Copp, B. R., McNeil, M. R., Wilson, M. A., & Barry, C. E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406796200 · Cited by 606
Pseudomonas aeruginosa Anaerobic Respiration in Biofilms
Yoon, S. S., Hennigan, R. F., Hilliard, G. M., Ochsner, U. A., Parvatiyar, K., Kamani, M. C., Allen, H. L., DeKievit, T. R., Gardner, P. R., Schwab, U., et al. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00295-2 · Cited by 585
Ojha, A. K., Baughn, A. D., Sambandan, D., Hsu, T., Trivelli, X., Guerardel, Y., Alahari, A., Kremer, L., Jacobs, W. R., & Hatfull, G. F. (2008) · Molecular Microbiology · doi:10.1111/j.1365-2958.2008.06274.x · Cited by 545
Non-inherited antibiotic resistance
Levin, B. R., & Rozen, D. E. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1445 · Cited by 542
Inhibition of Daptomycin by Pulmonary Surfactant: In Vitro Modeling and Clinical Impact
Silverman, J. A., Mortin, L. I., VanPraagh, A. D. G., Li, T., & Alder, J. (2005) · The Journal of Infectious Diseases · doi:10.1086/430352 · Cited by 541
Rao, S. P. S., Alonso, S., Rand, L., Dick, T., & Pethe, K. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711697105 · Cited by 517
Resch, A., Rosenstein, R., Nerz, C., & Götz, F. (2005) · Applied and Environmental Microbiology · doi:10.1128/aem.71.5.2663-2676.2005 · Cited by 492
Pamp, S. J., Gjermansen, M., Johansen, H. K., & Tolker‐Nielsen, T. (2008) · Molecular Microbiology · doi:10.1111/j.1365-2958.2008.06152.x · Cited by 486
Zhang, Y. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg446 · Cited by 477
Tuberculosis — metabolism and respiration in the absence of growth
Boshoff, H. I. M., & Barry, C. E. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1065 · Cited by 448
Straus, S. K., & Hancock, R. E. W. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.02.009 · Cited by 446
McPhee, J. B., Lewenza, S., & Hancock, R. E. W. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03673.x · Cited by 443
Deb, C., Lee, C.-M., Dubey, V. S., Daniel, J., Abomoelak, B., Sirakova, T. D., Pawar, S., Rogers, L., & Kolattukudy, P. E. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006077 · Cited by 440
At the Crossroads of Bacterial Metabolism and Virulence Factor Synthesis in Staphylococci
Somerville, G. A., & Proctor, R. A. (2009) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00005-09 · Cited by 392
Tuberculosis: a problem with persistence
Stewart, G. R., Robertson, B. D., & Young, D. B. (2003) · Nature Reviews Microbiology · doi:10.1038/nrmicro749 · Cited by 386
Fibroblasts Can Be Genetically Modified to Produce Excitable Cells Capable of Electrical Coupling
Kizana, E., Ginn, S. L., Allen, D. G., Ross, D. L., & Alexander, I. E. (2005) · Circulation · doi:10.1161/01.cir.0000153812.64956.ef · Cited by 382
Ernst, C. M., Staubitz, P., Mishra, N. N., Yang, S.-J., Hornig, G., Kalbacher, H., Bayer, A. S., Kraus, D., & Peschel, A. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000660 · Cited by 368
Diarylquinolines Are Bactericidal for Dormant Mycobacteria as a Result of Disturbed ATP Homeostasis
Koul, A., Vranckx, L., Dendouga, N., Balemans, W., Van den Wyngaert, I., Vergauwen, K., Göhlmann, H. W. H., Willebrords, R., Poncelet, A., Guillemont, J., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803899200 · Cited by 364
New Lipoglycopeptides: A Comparative Review of Dalbavancin, Oritavancin and Telavancin
Zhanel, G. G., Calic, D., Schweizer, F., Zelenitsky, S., Adam, H., Lagacé-Wiens, P. R. S., Rubinstein, E., Gin, A. S., Hoban, D. J., & Karlowsky, J. A. (2010) · Drugs · doi:10.2165/11534440-000000000-00000 · Cited by 352
Raad, I., Hanna, H., Jiang, Y., Dvorak, T., Reitzel, R., Chaiban, G., Sherertz, R., & Hachem, R. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00350-06 · Cited by 350
Zhang, L., Dhillon, P., Yan, H., Farmer, S., & Hancock, R. E. W. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.12.3317-3321.2000 · Cited by 349
VanA-Type Vancomycin-Resistant Staphylococcus aureus
Périchon, B., & Courvalin, P. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00346-09 · Cited by 334
Anaerobic Gene Expression in Staphylococcus aureus
Fuchs, S., Pané-Farré, J., Kohler, C., Hecker, M., & Engelmann, S. (2007) · Journal of Bacteriology · doi:10.1128/jb.00081-07 · Cited by 326
The mechanism of action of PA-824: Novel insights from transcriptional profiling
Manjunatha, U., Boshoff, H. I. M., & Barry, C. E. (2009) · Communicative & Integrative Biology · doi:10.4161/cib.2.3.7926 · Cited by 319
Jones, T., Yeaman, M. R., Sakoulas, G., Yang, S.-J., Proctor, R. A., Sahl, H.-G., Schrenzel, J., Xiong, Y. Q., & Bayer, A. S. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00719-07 · Cited by 318
Hassett, D. J., Cuppoletti, J., Trapnell, B., Lymar, S. V., Rowe, J. J., Sun Yoon, S., Hilliard, G. M., Parvatiyar, K., Kamani, M. C., Wozniak, D. J., et al. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00152-7 · Cited by 313
Lenaerts, A. J., Gruppo, V., Marietta, K. S., Johnson, C. M., Driscoll, D. K., Tompkins, N. M., Rose, J. D., Reynolds, R. C., & Orme, I. M. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.6.2294-2301.2005 · Cited by 306
Alvarez‐Ortega, C., & Harwood, C. S. (2007) · Molecular Microbiology · doi:10.1111/j.1365-2958.2007.05772.x · Cited by 304
Role of Global Regulators and Nucleotide Metabolism in Antibiotic Tolerance in Escherichia coli
Hansen, S., Lewis, K., & Vulić, M. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00144-08 · Cited by 300
Richardson, A. R., Libby, S. J., & Fang, F. C. (2008) · Science · doi:10.1126/science.1155207 · Cited by 296
Antimicrobial peptide mimics for improved therapeutic properties
Rotem, S., & Mor, A. (2009) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2008.10.020 · Cited by 296
Cho, S. H., Warit, S., Wan, B., Hwang, C. H., Pauli, G. F., & Franzblau, S. G. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00055-06 · Cited by 292
Inhibitors of type II NADH:menaquinone oxidoreductase represent a class of antitubercular drugs
Weinstein, E. A., Yano, T., Li, L.-S., Avarbock, D., Avarbock, A., Helm, D., McColm, A. A., Duncan, K., Lonsdale, J. T., & Rubin, H. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500469102 · Cited by 289
Rustomjee, R., Diacon, A. H., Allen, J., Venter, A., Reddy, C., Patientia, R. F., Mthiyane, T. C. P., De Marez, T., van Heeswijk, R., Kerstens, R., et al. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01204-07 · Cited by 278
Mechanism of action of oritavancin and related glycopeptide antibiotics
Allen, N. (2003) · FEMS Microbiology Reviews · doi:10.1016/s0168-6445(02)00144-4 · Cited by 276
Mascio, C. T. M., Alder, J. D., & Silverman, J. A. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00824-07 · Cited by 276
New Insights into Type II NAD(P)H:Quinone Oxidoreductases
Melo, A. M. P., Bandeiras, T. M., & Teixeira, M. (2004) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.68.4.603-616.2004 · Cited by 270
Acid Resistance in Mycobacterium tuberculosis
Vandal, O. H., Nathan, C. F., & Ehrt, S. (2009) · Journal of Bacteriology · doi:10.1128/jb.00305-09 · Cited by 263
Location of Persisting Mycobacteria in a Guinea Pig Model of Tuberculosis Revealed by R207910
Lenaerts, A. J., Hoff, D., Aly, S., Ehlers, S., Andries, K., Cantarero, L., Orme, I. M., & Basaraba, R. J. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00276-07 · Cited by 257
New Drugs against Tuberculosis: Problems, Progress, and Evaluation of Agents in Clinical Development
van den Boogaard, J., Kibiki, G. S., Kisanga, E. R., Boeree, M. J., & Aarnoutse, R. E. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00749-08 · Cited by 257
Daptomycin‐Resistant, Methicillin‐Resistant Staphylococcus aureus Bacteremia
Mangili, A., Bica, I., Snydman, D. R., & Hamer, D. H. (2005) · Clinical Infectious Diseases · doi:10.1086/428616 · Cited by 256
Interaction of staphylococci with bone
Wright, J. A., & Nair, S. P. (2010) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2009.10.003 · Cited by 255
Development of Daptomycin Resistance In Vivo in Methicillin-Resistant Staphylococcus aureus
Hayden, M. K., Rezai, K., Hayes, R. A., Lolans, K., Quinn, J. P., & Weinstein, R. A. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.10.5285-5287.2005 · Cited by 241
Karakousis, P. C., Yoshimatsu, T., Lamichhane, G., Woolwine, S. C., Nuermberger, E. L., Grosset, J., & Bishai, W. R. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040646 · Cited by 237
The equilibria that allow bacterial persistence in human hosts
Blaser, M. J., & Kirschner, D. (2007) · Nature · doi:10.1038/nature06198 · Cited by 236
Vázquez-Laslop, N., Lee, H., & Neyfakh, A. A. (2006) · Journal of Bacteriology · doi:10.1128/jb.188.10.3494-3497.2006 · Cited by 231
Combating bacteria and drug resistance by inhibiting mechanisms of persistence and adaptation
Smith, P. A., & Romesberg, F. E. (2007) · Nature Chemical Biology · doi:10.1038/nchembio.2007.27 · Cited by 222
Mishra, N. N., Yang, S.-J., Sawa, A., Rubio, A., Nast, C. C., Yeaman, M. R., & Bayer, A. S. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01682-08 · Cited by 216
Anti-biofilm properties of chitosan-coated surfaces
Carlson, R. P., Taffs, R., Davison, W. M., & Stewart, P. S. (2008) · Journal of Biomaterials Science, Polymer Edition · doi:10.1163/156856208784909372 · Cited by 213
Antibiotic tolerance among clinical isolates of bacteria
Tuomanen, E., Durack, D. T., & Tomasz, A. (1986) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.30.4.521 · Cited by 212
Keeping Their Options Open: Acute versus Persistent Infections
Furukawa, S., Kuchma, S. L., & O'Toole, G. A. (2006) · Journal of Bacteriology · doi:10.1128/jb.188.4.1211-1217.2006 · Cited by 204
Depolarization, Bacterial Membrane Composition, and the Antimicrobial Action of Ceragenins
Epand, R. F., Pollard, J. E., Wright, J. O., Savage, P. B., & Epand, R. M. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00380-10 · Cited by 198
Inhibition of staphylococcal biofilm formation by nitrite
Schlag, S., Nerz, C., Birkenstock, T. A., Altenberend, F., & Götz, F. (2007) · Journal of Bacteriology · doi:10.1128/jb.00598-07 · Cited by 196
Host cell phospholipids are trafficked to and then modified by Chlamydia trachomatis
Wylie, J. L., Hatch, G. M., & McClarty, G. (1997) · Journal of Bacteriology · doi:10.1128/jb.179.23.7233-7242.1997 · Cited by 195
Walsh, T. J., Yeldandi, V., McEvoy, M., Gonzalez, C., Chanock, S., Freifeld, A., Seibel, N. I., Whitcomb, P. O., Jarosinski, P., Boswell, G., et al. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.9.2391 · Cited by 189
Biswas, L., Biswas, R., Schlag, M., Bertram, R., & Götz, F. (2009) · Applied and Environmental Microbiology · doi:10.1128/aem.01211-09 · Cited by 182
Coates, T., Bax, R., & Coates, A. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp159 · Cited by 181
Oritavancin Kills Stationary-Phase and Biofilm Staphylococcus aureus Cells In Vitro
Belley, A., Neesham-Grenon, E., McKay, G., Arhin, F. F., Harris, R., Beveridge, T., Parr, T. R., & Moeck, G. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00766-08 · Cited by 178
Synergistic Activity of R207910 Combined with Pyrazinamide against Murine Tuberculosis
Ibrahim, M., Andries, K., Lounis, N., Chauffour, A., Truffot-Pernot, C., Jarlier, V., & Veziris, N. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00898-06 · Cited by 175
Sisson, G., Goodwin, A., Raudonikiene, A., Hughes, N. J., Mukhopadhyay, A. K., Berg, D. E., & Hoffman, P. S. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.7.2116-2123.2002 · Cited by 167
Antimicrobial Treatment of Chronic Osteomyelitis
Mader, J. T., Shirtliff, M. E., Bergquist, S. C., & Calhoun, J. (1999) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-199903000-00008 · Cited by 165
Besier, S., Smaczny, C., von Mallinckrodt, C., Krahl, A., Ackermann, H., Brade, V., & Wichelhaus, T. A. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.01510-06 · Cited by 164
Reutericyclin: biological activity, mode of action, and potential applications
Gänzle, M. G. (2004) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-003-1536-8 · Cited by 156
Persistence of Mycoplasma genitalium Following Azithromycin Therapy
Bradshaw, C. S., Chen, M. Y., & Fairley, C. K. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003618 · Cited by 154
Yano, T., Li, L.-S., Weinstein, E., Teh, J.-S., & Rubin, H. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m508844200 · Cited by 150
The bacterial envelope as a target for novel anti-MRSA antibiotics
Françoise Van Bambeke, A., Mingeot‐Leclercq, M., Struelens, M. J., & Tulkens, P. M. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.12.004 · Cited by 149
Genetic Basis for Natural and Acquired Resistance to the Diarylquinoline R207910 in Mycobacteria
Petrella, S., Cambau, E., Chauffour, A., Andries, K., Jarlier, V., & Sougakoff, W. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00244-06 · Cited by 147
Dhiman, R. K., Mahapatra, S., Slayden, R. A., Boyne, M. E., Lenaerts, A., Hinshaw, J. C., Angala, S. K., Chatterjee, D., Biswas, K., Narayanasamy, P., et al. (2009) · Molecular Microbiology · doi:10.1111/j.1365-2958.2009.06625.x · Cited by 146
Interrelationships between Colonies, Biofilms, and Planktonic Cells of Pseudomonas aeruginosa
Mikkelsen, H., Duck, Z., Lilley, K. S., & Welch, M. (2007) · Journal of Bacteriology · doi:10.1128/jb.01687-06 · Cited by 146
Rose, W. E., & Poppens, P. T. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn513 · Cited by 141
Characterization of mRNA Interferases from Mycobacterium tuberculosis
Zhu, L., Zhang, Y., Teh, J. S., Zhang, J., Connell, N. D., Rubin, H. N., & Inouye, M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512693200 · Cited by 136
Differential Antibiotic Susceptibilities of Starved Mycobacterium tuberculosis Isolates
Xie, Z., Siddiqi, N., & Rubin, E. J. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.11.4778-4780.2005 · Cited by 136
Exploiting current understanding of antibiotic action for discovery of new drugs
Chopra, I., Hesse, L., & O’Neill, A. J. (2002) · Journal of Applied Microbiology · doi:10.1046/j.1365-2672.92.5s1.13.x · Cited by 130
Self-citationNitazoxanide Kills Replicating and Nonreplicating Mycobacterium tuberculosis and Evades Resistance
de Carvalho, L. P. S., Lin, G., Jiang, X., & Nathan, C. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm9010719 · Cited by 129
Yang, S., Kreiswirth, B. N., Sakoulas, G., Yeaman, M. R., Xiong, Y. Q., Sawa, A., & Bayer, A. S. (2009) · The Journal of Infectious Diseases · doi:10.1086/648473 · Cited by 126
A Comparative Review of the Lipoglycopeptides: Oritavancin, Dalbavancin, and Telavancin
Guskey, M. T., & Tsuji, B. T. (2009) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.30.1.80 · Cited by 123
Dekkers, L. C., van der Bij, A. J., Mulders, I. H. M., Phoelich, C. C., Wentwoord, R. A. R., Glandorf, B., Wijffelman, C. A., & Lugtenberg, B. J. J. (1998) · Molecular Plant-Microbe Interactions · doi:10.1094/mpmi.1998.11.8.763 · Cited by 123
Upadhayaya, R. S., Vandavasi, J. K., Vasireddy, N. R., et al. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.02.026 · Cited by 122
Transcriptional regulation in bacterial membrane lipid synthesis
Zhang, Y., & Rock, C. O. (2008) · Journal of Lipid Research · doi:10.1194/jlr.r800046-jlr200 · Cited by 107
How Nature Morphs Peptide Scaffolds into Antibiotics
Nolan, E. M., & Walsh, C. T. (2008) · ChemBioChem · doi:10.1002/cbic.200800438 · Cited by 106
Antimicrobial Activities of Ceragenins against Clinical Isolates of Resistant Staphylococcus aureus
Chin, J. N., Rybak, M. J., Cheung, C. M., & Savage, P. B. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01325-06 · Cited by 101
Kosowska-Shick, K., Clark, C., Pankuch, G. A., McGhee, P., Dewasse, B. E., Beachel, L., & Appelbaum, P. C. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00742-09 · Cited by 101
Béven, L., & Wróblewski, H. (1997) · Research in Microbiology · doi:10.1016/s0923-2508(97)87647-4 · Cited by 99
Kashket, E. R. (1981) · Journal of Bacteriology · doi:10.1128/jb.146.1.377-384.1981 · Cited by 96
Ooi, N., Miller, K., Randall, C. P., Rhys‐Williams, W., Love, W. C., & Chopra, I. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp409 · Cited by 94
Self-citationDomènech, Ò., Francius, G., Tulkens, P. M., Françoise Van Bambeke, A., Dufrêne, Y. F., & Mingeot‐Leclercq, M. (2009) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2009.05.003 · Cited by 92
XF-73, a novel antistaphylococcal membrane-active agent with rapid bactericidal activity
Ooi, N., Miller, K., Hobbs, J. K., Rhys‐Williams, W., Love, W. C., & Chopra, I. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp299 · Cited by 92
Self-citationLaPlante, K. L., & Mermel, L. A. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm141 · Cited by 91
Amaral, L., Boeree, M. J., Gillespie, S. H., Udwadia, Z., & van Soolingen, D. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.12.019 · Cited by 90
Flemming, K., Klingenberg, C., Cavanagh, J. P., Sletteng, M., Stensen, W., Svendsen, J. S. M., & Flægstad, T. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn464 · Cited by 90
Respiratory ATP synthesis: the new generation of mycobacterial drug targets?
Bald, D., & Koul, A. (2010) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2010.01959.x · Cited by 87
LaPlante, K. L., & Mermel, L. A. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01642-08 · Cited by 82
Hu, Y., Shamaei‐Tousi, A., Liu, Y., & Coates, A. R. M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011818 · Cited by 80
Anaerobic incubation conditions enhance pyrazinamide activity against Mycobacterium tuberculosis
Wade, M. M., & Zhang, Y. (2004) · Journal of Medical Microbiology · doi:10.1099/jmm.0.45639-0 · Cited by 80
Gotfried, M. H., Shaw, J., Benton, B. M., Krause, K. M., Goldberg, M. R., Kitt, M. M., & Barriere, S. L. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00875-07 · Cited by 79
Targeting non-multiplying organisms as a way to develop novel antimicrobials
Coates, A. R. M., & Hu, Y. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.12.001 · Cited by 79
Arthur, M., Depardieu, F., Reynolds, P. E., & Courvalin, P. M. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.8.1875 · Cited by 77
Purdy, G. E., Niederweis, M., & Russell, D. G. (2009) · Molecular Microbiology · doi:10.1111/j.1365-2958.2009.06801.x · Cited by 76
Allen, N. E., LeTourneau, D. L., & Hobbs, J. N. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.1.66 · Cited by 76
Contribution of Oxygen-Limiting Conditions to Persistent Infection of Pseudomonas Aeruginosa
Schobert, M., & Tielen, P. (2010) · Future Microbiology · doi:10.2217/fmb.10.16 · Cited by 72
Phospholipid Composition of PurifiedChlamydia trachomatisMimics That of the Eucaryotic Host Cell
Hatch, G. M., & McClarty, G. A. (1998) · Infection and Immunity · doi:10.1128/iai.66.8.3727-3735.1998 · Cited by 72
Impact of sarA on Daptomycin Susceptibility of Staphylococcus aureus Biofilms In Vivo
Weiss, E. C., Zielinska, A., Beenken, K. E., Spencer, H. J., Daily, S. T., & Smeltzer, M. S. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00484-09 · Cited by 70
Anti-staphylococcal activity and mode of action of clofazimine
Oliva, B. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh114 · Cited by 65
Pre-clinical experience with daptomycin
Hawkey, P. M. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn367 · Cited by 65
Lampe, M. F., Ballweber, L., Isaacs, C. E., Patton, D. L., & Stamm, W. E. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.5.1239 · Cited by 57
Kalia, V., Miglani, R., Purnapatre, K. P., Mathur, T., Singhal, S., Khan, S. I., Voleti, S. R., Upadhyay, D. J., Saini, K. S., Rattan, A., et al. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00887-08 · Cited by 54
Identification of new inhibitors for alternative NADH dehydrogenase (NDH-II)
Mogi, T., Matsushita, K., Murase, Y., Kawahara, K., Miyoshi, H., Ui, H., Shiomi, K., Ōmura, S., & Kita, K. (2008) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2008.01451.x · Cited by 52
Falsetta, M. L., McEwan, A. G., Jennings, M. P., & Apicella, M. A. (2010) · Infection and Immunity · doi:10.1128/iai.01312-09 · Cited by 49
Shamir, E. R., Warthan, M., Brown, S. P., Nataro, J. P., Guerrant, R. L., & Hoffman, P. S. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01279-09 · Cited by 45
Лазарев, В. Н., Parfenova, T. M., Gularyan, S. K., Misyurina, O. Y., Акопян, Т. А., & Govorun, V. M. (2002) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(01)00479-4 · Cited by 44
Cardoso, R. F., Cardoso, M. A., Leite, C. Q. F., Sato, D. N., Mamizuka, E. M., Hirata, R. D. C., de Mello, F. A. F., & Hirata, M. H. (2007) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/s0074-02762007000100009 · Cited by 42
Mogi, T., Ui, H., Shiomi, K., Ōmura, S., Miyoshi, H., & Kita, K. (2008) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2008.11.016 · Cited by 37
Nir‐Paz, R., Prévost, M., Nicolas, P., Blanchard, A., & Wróblewski, H. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.5.1218-1225.2002 · Cited by 31
Tchouaffi-Nana, F., Ballard, T. E., Cary, C. H., Macdonald, T. L., Sifri, C. D., & Hoffman, P. S. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00901-09 · Cited by 30
Domènech, Ò., Dufrêne, Y. F., Françoise Van Bambeke, A., Tukens, P. M., & Mingeot‐Leclercq, M. (2010) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2010.06.011 · Cited by 28
Лазарев, В. Н., Shkarupeta, M. M., Titova, G. A., Kostrjukova, E. S., Акопян, Т. А., & Govorun, V. M. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.10.028 · Cited by 27
Hurdle, J. G., Yendapally, R., Sun, D., et al. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00457-09 · Cited by 25
Self-citationDaptomycin in endocarditis and bacteraemia: a British perspective
Warren, R. E. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn370 · Cited by 18
Northen, H., Paterson, G. K., Constantino‐Casas, F., Bryant, C. E., Clare, S., Mastroeni, P., Peters, S. E., & Maskell, D. J. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.10.146 · Cited by 15
Cholo, M. C., van Rensburg, E. J., & Anderson, R. (2008) · Southern African Journal of Epidemiology and Infection · doi:10.1080/10158782.2008.11441327 · Cited by 12
Cited by
A Deep Learning Approach to Antibiotic Discovery
Stokes, J. M., Yang, K., Swanson, K., Jin, W., Cubillos-Ruiz, A., Donghia, N. M., MacNair, C. R., French, S., Carfrae, L. A., Bloom-Ackermann, Z., et al. (2020) · Cell · doi:10.1016/j.cell.2020.01.021 · Cited by 2,463
Nanomaterial-based therapeutics for antibiotic-resistant bacterial infections
Makabenta, J. M. V., Nabawy, A., Li, C.-H., Schmidt-Malan, S., Patel, R., & Rotello, V. M. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-020-0420-1 · Cited by 1,397
Persistent bacterial infections and persister cells
Fisher, R. A., Gollan, B., & Helaine, S. (2017) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.42 · Cited by 1,243
Molecular mechanisms of membrane targeting antibiotics
Epand, R. M., Walker, C., Epand, R. F., & Magarvey, N. A. (2016) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2015.10.018 · Cited by 666
Novel classes of antibiotics or more of the same?
Coates, A. R., Halls, G., & Hu, Y. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01250.x · Cited by 598
Metadata
- Authors
- Hurdle, J. G., O'Neill, A. J., Chopra, I., & Lee, R. E.
- Venue
- Nature Reviews Microbiology
- Published
- 2010-12-16
- Volume
- 9
- Issue
- 1
- Pages
- 62-75
- ISSN
- 1740-1526 (ISSN-L)
- 1740-1534
- OpenAlex
- W1989761771
- Cited by
- 871
- References
- 140
- FWCI
- 2.67
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.